Case todayBrokenRevenue decline · Nov 17, 2026The case · mixed · Nov 8, 2026Own NPT if Texxon is a high-throughput, ultra-thin-spread chemicals wholesaler whose equity value depends less on sales growth than on proving that its sourcing, customer access, and working-capital model can produce durable gross spread and cash.5 conditions1 strengthening · 1 holding · 3 weakeningNext resultsNot scheduledNo date filed yet

NPT at a glance

The past year

Chart

−51.5% $1.75, close Nov 16

From the highest close
−91.5%
Vs the 200-day average
−57.9%
Nov 14, 2025Daily close, Texxon HoldingNov 16, 2026

Short interest

History

1,521 shares

Since the last report
−2.7%
Days to cover
1.0 day
Settled
Oct 30, 2026

Insider buying, 7 days

Filings

None filed this week

Form 4s filed
Nov 10 – Nov 16

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

NPT price history

Latest price$1.75Today−$0.03 (-1.69%)
NPT +0.00%S&P 500 -3.79%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Texxon’s supplier/customer access continues to convert chemicals-wholesale demand into rising throughput, but that access must be more than pass-through commodity volume to create value.StrengtheningMateriality: High

    GAAP annual revenue rose from $552.5 million in FY2023 to $672.7 million in FY2024 and $797.1 million in FY2025. If access is durable, scale can support future spread capture; if it is not, revenue can disappear or grow without benefiting equity holders.

    Watch: Chemical suppliers choose to sell directly to Texxon’s customers, reducing the need for an intermediary.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue rose from $552.5 million in FY2023 to $672.7 million in FY2024 and $797.1 million in FY2025.

    Open source ↗
  • Texxon has not yet shown that its procurement, logistics, or customer relationships give it pricing power; in a commodity-like wholesale model, competitors and counterparties can absorb the economics of scale.WeakeningMateriality: High

    GAAP annual gross profit was $4.7 million in FY2025, down from $4.8 million in FY2024 despite higher revenue. Revenue growth only creates shareholder value if Texxon keeps enough gross spread to cover overhead, financing risk, and dilution risk.

    Watch: Regional chemicals distributors undercut Texxon on price and force it to sacrifice spread to keep volume.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit was $4.7 million in FY2025, down from $4.8 million in FY2024 despite higher revenue.

    Open source ↗
  • Texxon must prove that overhead and compliance costs can be absorbed by gross spread; otherwise scale makes the company larger without making it economically profitable.WeakeningMateriality: Medium

    GAAP annual operating income declined from $1.25 million in FY2023 to $0.66 million in FY2024 and then to a $0.60 million operating loss in FY2025. A return to operating profitability would show the business model can convert spread into owner earnings; persistent losses would imply volume is structurally low quality.

    Watch: Public-company, logistics, credit-control, or personnel costs remain structurally higher than Texxon’s gross spread can fund.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income declined from $1.25 million in FY2023 to $0.66 million in FY2024 and then to a $0.60.

    Open source ↗
  • The operating model depends on disciplined working-capital recycling; thin-margin chemicals trading can survive only if receivables, inventory, payables, and supplier credit do not consume cash as volume grows.HoldingMateriality: Medium

    GAAP annual operating cash flow turned positive at $2.3 million in FY2025 after cash outflows of $30.8 million in FY2024 and $14.2 million in FY2023. If working capital self-funds, Texxon can grow without constant external capital; if not, lenders and dilution, not operations, determine shareholder outcomes.

    Watch: Customers demand longer payment terms while suppliers demand faster payment or prepayment.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow turned positive at $2.3 million in FY2025 after cash outflows of $30.8 million in FY2024.

    Open source ↗
  • Texxon’s negative equity makes creditor and supplier confidence a core part of the moat; without continued trade credit and financing access, the company cannot reliably fund high-volume low-margin distribution.WeakeningMateriality: Medium

    Stockholders’ equity was negative $3.8 million at June 30, 2025, worse than negative $2.8 million at June 30, 2024. Balance-sheet fragility can force dilution, constrain growth, or shift economics to creditors even if customer demand remains present.

    Watch: Suppliers tighten trade-credit limits or require cash-on-delivery terms.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Stockholders’ equity was negative $3.8 million at June 30, 2025, worse than negative $2.8 million at June 30, 2024.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Texxon’s supplier/customer access continues to convert chemicals-wholesale demand into rising throughput, but that access must be more than pass-through commodity volume to create value. If access is durable, scale can support future spread capture; if it is not, revenue can disappear or grow without benefiting equity holders.

Texxon has not yet shown that its procurement, logistics, or customer relationships give it pricing power; in a commodity-like wholesale model, competitors and counterparties can absorb the economics of scale. Revenue growth only creates shareholder value if Texxon keeps enough gross spread to cover overhead, financing risk, and dilution risk.

Texxon must prove that overhead and compliance costs can be absorbed by gross spread; otherwise scale makes the company larger without making it economically profitable. A return to operating profitability would show the business model can convert spread into owner earnings; persistent losses would imply volume is structurally low quality.

The operating model depends on disciplined working-capital recycling; thin-margin chemicals trading can survive only if receivables, inventory, payables, and supplier credit do not consume cash as volume grows. If working capital self-funds, Texxon can grow without constant external capital; if not, lenders and dilution, not operations, determine shareholder outcomes.

Texxon’s negative equity makes creditor and supplier confidence a core part of the moat; without continued trade credit and financing access, the company cannot reliably fund high-volume low-margin distribution. Balance-sheet fragility can force dilution, constrain growth, or shift economics to creditors even if customer demand remains present.

All standing thesis claims
Original report summary

Texxon is a high-throughput, ultra-thin-spread chemicals wholesaler whose equity value depends less on sales growth than on proving that its sourcing, customer access, and working-capital model can produce durable gross spread and cash.

Evidence assessed Nov 8, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Texxon Holding

Where the evidence on Texxon Holding disagrees: Mixed on the latest evidence (Nov 8, 2026). Of its 5 thesis points, 1 strengthening, 1 holding and 3 weakening.

Bull case: what the evidence supports

  • Texxon’s supplier/customer access continues to convert chemicals-wholesale demand into rising throughput, but that access must be more than pass-through commodity volume to create value.

    sec.gov ↗

  • The operating model depends on disciplined working-capital recycling; thin-margin chemicals trading can survive only if receivables, inventory, payables, and supplier credit do not consume cash as volume grows.

    sec.gov ↗

Bear case: what the evidence questions

  • Texxon has not yet shown that its procurement, logistics, or customer relationships give it pricing power; in a commodity-like wholesale model, competitors and counterparties can absorb the economics of scale.

    sec.gov ↗

  • Texxon must prove that overhead and compliance costs can be absorbed by gross spread; otherwise scale makes the company larger without making it economically profitable.

    sec.gov ↗

  • Texxon’s negative equity makes creditor and supplier confidence a core part of the moat; without continued trade credit and financing access, the company cannot reliably fund high-volume low-margin distribution.

    sec.gov ↗

Thesis-Break Engine

What has broken in Texxon Holding’s thesis

Each break OptimistFi flagged on Texxon Holding, dated — with what has historically followed the same kind of break across the market, not a forecast for Texxon Holding.

peers+17%-20%-1%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -1% path vs comparable companies over six months, inside the middle-half range (+17% to -20%). A base rate, not a forecast.
  • Revenue declinecondition set before this filing

    Across all companies, this kind of break has happened 8,727 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 37% of them trailed it by 10 points or more.

  • Late SEC filingcondition set before this filing

    Across all companies, this kind of break has happened 4,811 times before. Those stocks trailed comparable companies by a median of 12% over the next six months, and 52% of them trailed it by 10 points or more.

Several kinds of break have stacked on Texxon Holding at once. A cluster is a stronger read than any one signal alone.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    REPORT OF FOREIGN PRIVATE ISSUER.

    Texxon Holding filed an SEC report on 2026-06-30: REPORT OF FOREIGN PRIVATE ISSUER. It is a dated development that tests the current thesis.

  2. Mixed
    REPORT OF FOREIGN PRIVATE ISSUER.

    Texxon Holding filed an SEC report on 2026-05-28: REPORT OF FOREIGN PRIVATE ISSUER. It is a dated development that tests the current thesis.

  3. Mixed
    CURRENT REPORT.

    Texxon Holding filed an SEC report on 2026-04-28: CURRENT REPORT. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Chemical suppliers choose to sell directly to Texxon’s customers, reducing the need for an intermediary.
  • Regional chemicals distributors undercut Texxon on price and force it to sacrifice spread to keep volume.
  • Public-company, logistics, credit-control, or personnel costs remain structurally higher than Texxon’s gross spread can fund.
  • Customers demand longer payment terms while suppliers demand faster payment or prepayment.
  • Suppliers tighten trade-credit limits or require cash-on-delivery terms.

NPT news

Loading headlines…

Financial statements

NPT income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

NPT: quick answers

What is NPT's short interest?
As of October 30, 2026, 1,521 NPT shares were sold short, down 2.7% from the count before. At the stock's average daily volume that is 1.0 day to cover. FINRA publishes the count twice a month. NPT short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.